Cargando…

miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro

Downregulation of miR-221-3p expression in prostate cancer (PCa) predicted overall and cancer-specific survival of high-risk PCa patients. Apart from PCa, miR-221-3p expression levels predicted a response to tyrosine kinase inhibitors (TKI) in clear cell renal cell carcinoma (ccRCC) patients. Since...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krebs, Markus, Solimando, Antonio Giovanni, Kalogirou, Charis, Marquardt, André, Frank, Torsten, Sokolakis, Ioannis, Hatzichristodoulou, Georgios, Kneitz, Susanne, Bargou, Ralf, Kübler, Hubert, Schilling, Bastian, Spahn, Martin, Kneitz, Burkhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141373/ https://www.ncbi.nlm.nih.gov/pubmed/32131507 http://dx.doi.org/10.3390/jcm9030670

Ejemplares similares

miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1
por: Krebs, Markus, et al.
Publicado: (2019)

Critical Evaluation of a microRNA-Based Risk Classifier Predicting Cancer-Specific Survival in Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava
por: Kotlyar, Mischa J., et al.
Publicado: (2023)

Impact of miR-21, miR-126 and miR-221 as Prognostic Factors of Clear Cell Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava
por: Vergho, Daniel Claudius, et al.
Publicado: (2014)

Identification of miR-21-5p and miR-210-3p serum levels as biomarkers for patients with papillary renal cell carcinoma: a multicenter analysis
por: Kalogirou, Charis, et al.
Publicado: (2020)

Subgroup-Independent Mapping of Renal Cell Carcinoma—Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries
por: Marquardt, André, et al.
Publicado: (2021)

MiR-205 Is Progressively Down-Regulated in Lymph Node Metastasis but Fails as a Prognostic Biomarker in High-Risk Prostate Cancer
por: Kalogirou, Charis, et al.
Publicado: (2013)

miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo
por: Kiener, Mirjam, et al.
Publicado: (2019)

Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside
por: Solimando, Antonio Giovanni, et al.
Publicado: (2022)

High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer
por: Eckhardt, Carolin, et al.
Publicado: (2021)

Predicting Microenvironment in CXCR4- and FAP-Positive Solid Tumors—A Pan-Cancer Machine Learning Workflow for Theranostic Target Structures
por: Marquardt, André, et al.
Publicado: (2023)

Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma
por: Vergho, Daniel, et al.
Publicado: (2014)

Distinct microRNA Expression Profile in Prostate Cancer Patients with Early Clinical Failure and the Impact of let-7 as Prognostic Marker in High-Risk Prostate Cancer
por: Schubert, Maria, et al.
Publicado: (2013)

Mucin-Poor Mucinous Tubular and Spindle Cell Carcinoma of the Kidney Presented with Multiple Metastases Two Years after Nephrectomy: An Atypical Behaviour of a Rare, Indolent Tumour
por: Sokolakis, I., et al.
Publicado: (2017)

Metabolic Tumour Volume from PSMA PET/CT Scans of Prostate Cancer Patients during Chemotherapy—Do Different Software Solutions Deliver Comparable Results?
por: Hartrampf, Philipp E., et al.
Publicado: (2020)

Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohort
por: Marra, Giancarlo, et al.
Publicado: (2022)

Long-Term Results after Surgical Treatment of Congenital Penile Curvature Using a Modified Nesbit Technique
por: Sokolakis, Ioannis, et al.
Publicado: (2020)

Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration
por: Hailer, Amelie, et al.
Publicado: (2014)

COVID‑19‑related postponement of elective sexual or reproductive health operations deteriorates private and sexual life: an ongoing nightmare study
por: Pyrgidis, Nikolaos, et al.
Publicado: (2022)

PRAME Expression as Helpful Immunohistochemical Marker in Rhabdoid Melanoma
por: Glutsch, Valerie, et al.
Publicado: (2022)

MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer
por: Kalogirou, C., et al.
Publicado: (2021)

Somatic Hypermutation in Muts Homologue (Msh)3-, Msh6-, and Msh3/Msh6-Deficient Mice Reveals a Role for the Msh2–Msh6 Heterodimer in Modulating the Base Substitution Pattern
por: Wiesendanger, Margrit, et al.
Publicado: (2000)

A comprehensive narrative review of residual curvature correction during penile prosthesis implantation in patients with severe erectile dysfunction and concomitant Peyronie’s disease
por: Sokolakis, Ioannis, et al.
Publicado: (2021)

Avelumab in metastatic collecting duct carcinoma of the kidney: a case report
por: Pyrgidis, Nikolaos, et al.
Publicado: (2023)

Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
por: Glutsch, Valerie, et al.
Publicado: (2021)

Influence of VEGFR single nucleotide polymorphisms on the efficacy of sunitinib therapy against renal cell carcinoma
por: Liu, Rui, et al.
Publicado: (2017)

Synthesis, Characterization and in vitro Studies of a Cathepsin B‐Cleavable Prodrug of the VEGFR Inhibitor Sunitinib
por: Karnthaler‐Benbakka, Claudia, et al.
Publicado: (2018)

Infektionsprophylaxe bei rheumatologischen Erkrankungen
por: Kneitz, Christian, et al.
Publicado: (2020)

EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?
por: Bresciani, Giulia, et al.
Publicado: (2019)

PKPD Modeling of VEGF, sVEGFR-2, sVEGFR-3, and sKIT as Predictors of Tumor Dynamics and Overall Survival Following Sunitinib Treatment in GIST
por: Hansson, E K, et al.
Publicado: (2013)

The Interleukin 2 Receptor α Chain/CD25 Promoter Is a Target for Nuclear Factor of Activated T Cells
por: Schuh, Kai, et al.
Publicado: (1998)

Wichtigste Impfungen bei Patienten mit rheumatologischen Erkrankungen und warum
por: Kneitz, C., et al.
Publicado: (2020)

Meta-analysis on the association of VEGFR1 genetic variants with sunitinib outcome in metastatic renal cell carcinoma patients
por: Liu, Xiaoyan, et al.
Publicado: (2016)

Sunitinib in metastatic thymic carcinomas: Laboratory findings and initial clinical experience
por: Ströbel, P, et al.
Publicado: (2010)

The Role of Adjuvant Hormonal Treatment after Surgery for Localized High-Risk Prostate Cancer: Results of a Matched Multiinstitutional Analysis
por: Schubert, Maria, et al.
Publicado: (2012)

Low frequency of p16(INK4a) promoter methylation in mammary carcinomas as revealed by positive display of methylated sites
por: Lilischkis, R, et al.
Publicado: (2000)

CD10-Positive Cutaneous PEComa: An Extremely Rare Skin Tumour
por: Ueberschaar, Simon, et al.
Publicado: (2020)

Targeting VEGF-VEGFR Pathway by Sunitinib in Peripheral Primitive Neuroectodermal Tumor, Paraganglioma and Epithelioid Hemangioendothelioma: Three Case Reports
por: Prochilo, Tiziana, et al.
Publicado: (2013)

VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib
por: Scartozzi, M, et al.
Publicado: (2013)

Blood Vessel Density in Basal Cell Carcinomas and Benign Trichogenic Tumors as a Marker for Differential Diagnosis in Dermatopathology
por: Winter, Julia, et al.
Publicado: (2011)

Dermpath & Clinic: Where the shoe pinches — painful plantar plaque
por: Frings, Verena G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_toamec7m9bu44hepuknkbn5gdb